Monitoring approach: Establish clear metrics (visual field, OCT, visual acuity), measure every 3-6 months, continue peptides if stable or improving, consider break if stable 12+ months on treatment, resume immediately if decline detected during break, accept ongoing use if clearly beneficial and well-tolerated
If youre considering BPC 157 as part of your wellness plan or want to learn more about stem cell therapy, THE RE/ CLINIC is here to guide you every step of the way
The long-term benefits and side effects are unknown within the human body
doi:10.1016/j.amjcard.2015.08.046 Selim BJ, Ramar K
Can women use IGF-1 LR3 or DES
Diabetes Obes Metab 14(4):304314 Barski L, Eshkoli T, Brandstaetter E, Jotkowitz A (2019) Euglycemic diabetic ketoacidosis